Graham Casey
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Supplementary Figure S5 shows the age-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Supplementary Figure S4 shows the family-history-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Background: Tobacco smoking is an established risk factor for colorectal cancer. However, genetically defined population subgroups may have increased susceptibility to smoking-related effects on colorectal cancer. Methods: A genome-wide interaction scan was performed including 33,756 colorectal cancer cases and 44,346 controls from three genetic consortia. Results: Evidence of an interaction was observed between smoking status (ever vs. never smokers) and a locus on 3p12.1 (rs9880919, P = 4.58 × 10 −8 ), with higher associated risk in subjects carrying the GG genotype [OR, 1.25; 95% confidence interval (CI), 1.20–1.30] compared with the other genotypes (OR P = 1.72 × 10 −8 ) and 8q24.23 (rs7005722, P = 2.88 × 10 −8 ). Subjects carrying the rs4151657 TT genotype showed higher risk (OR, 1.12; 95% CI, 1.09–1.16) compared with the other genotypes (OR CADM2 (3p12.1) and ATF6B (6p21.33). Conclusions: Our study identified novel genetic loci that may modulate the risk for colorectal cancer of smoking status and intensity, linked to tumor suppression and immune response. Impact: These findings can guide potential prevention treatments.
Year:
2025
Supplementary Figure S2 shows the sex-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Background: Polygenic risk scores (PRS) which summarize individuals’ genetic risk profile may enhance targeted colorectal cancer screening. A critical step towards clinical implementation is rigorous external validations in large community-based cohorts. This study externally validated a PRS-enhanced colorectal cancer risk model comprising 140 known colorectal cancer loci to provide a comprehensive assessment on prediction performance. Methods: The model was developed using 20,338 individuals and externally validated in a community-based cohort ( n = 85,221). We validated predicted 5-year absolute colorectal cancer risk, including calibration using expected-to-observed case ratios (E/O) and calibration plots, and discriminatory accuracy using time-dependent AUC. The PRS-related improvement in AUC, sensitivity and specificity were assessed in individuals of age 45 to 74 years (screening-eligible age group) and 40 to 49 years with no endoscopy history (younger-age group). Results: In European-ancestral individuals, the predicted 5-year risk calibrated well [E/O = 1.01; 95% confidence interval (CI), 0.91–1.13] and had high discriminatory accuracy (AUC = 0.73; 95% CI, 0.71–0.76). Adding the PRS to a model with age, sex, family and endoscopy history improved the 5-year AUC by 0.06 ( P P = 0.05) in the screening-eligible age and younger-age groups, respectively. Using a risk-threshold of 5-year SEER colorectal cancer incidence rate at age 50 years, adding the PRS had a similar sensitivity but improved the specificity by 11% ( P P = 0.04) with similar specificity. Conclusions: The proposed PRS-enhanced model provides a well-calibrated 5-year colorectal cancer risk prediction and improves discriminatory accuracy in the external cohort. Impact: The proposed model has potential utility in risk-stratified colorectal cancer prevention.
Year:
2025
Supplementary Figure S3 shows the endoscopy-history-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Supplementary methods show the details of study population, risk model development, calculation of the polygenic risk score, statistical analysis and funding of individual studies in GECCO and CORECT.
Year:
2025
Colorectal cancer risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment interactions (G × E) can provide biological insights into the effects of obesity on colorectal cancer risk. Here, we assessed potential genome-wide G × E interactions between body mass index (BMI) and common SNPs for colorectal cancer risk using data from 36,415 colorectal cancer cases and 48,451 controls from three international colorectal cancer consortia (CCFR, CORECT, and GECCO). The G × E tests included the conventional logistic regression using multiplicative terms (one degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G × E interactions under specific conditions. BMI was associated with higher colorectal cancer risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 ( FMN1/GREM1 ) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher colorectal cancer risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with colorectal cancer risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and colorectal cancer. Significance: This gene-environment interaction analysis revealed a genetic locus in FMN1/GREM1 that interacts with body mass index in colorectal cancer risk, suggesting potential implications for precision prevention strategies.
Year:
2025
Colorectal cancer (CRC) risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment (G×E) interactions can provide biological insights into the effects of obesity on CRC risk. Here, we assessed potential genome-wide G×E interactions between body mass index (BMI) and common single nucleotide polymorphisms (SNPs) for CRC risk using data from 36,415 CRC cases and 48,451 controls from three international CRC consortia (CCFR, CORECT, and GECCO). The G×E tests included the conventional logistic regression using multiplicative terms (one-degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G×E interactions under specific conditions. BMI was associated with higher CRC risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 (FMN1/GREM1) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher CRC risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with CRC risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and CRC.
Year:
2024
Alternative polyadenylation (APA) modulates mRNA processing in the 3′-untranslated regions (3′ UTR), affecting mRNA stability and translation efficiency. Research into genetically regulated APA has the potential to provide insights into cancer risk. In this study, we conducted large APA-wide association studies to investigate associations between APA levels and cancer risk. Genetic models were built to predict APA levels in multiple tissues using genotype and RNA sequencing data from 1,337 samples from the Genotype-Tissue Expression project. Associations of genetically predicted APA levels with cancer risk were assessed by applying the prediction models to data from large genome-wide association studies of six common cancers among European ancestry populations: breast, ovarian, prostate, colorectal, lung, and pancreatic cancers. A total of 58 risk genes (corresponding to 76 APA sites) were associated with at least one type of cancer, including 25 genes previously not linked to cancer susceptibility. Of the identified risk APAs, 97.4% and 26.3% were supported by 3′-UTR APA quantitative trait loci and colocalization analyses, respectively. Luciferase reporter assays for four selected putative regulatory 3′-UTR variants demonstrated that the risk alleles of 3′-UTR variants, rs324015 ( STAT6 ), rs2280503 ( DIP2B ), rs1128450 ( FBXO38 ), and rs145220637 ( LDHA ), significantly increased the posttranscriptional activities of their target genes compared with reference alleles. Furthermore, knockdown of the target genes confirmed their ability to promote proliferation and migration. Overall, this study provides insights into the role of APA in the genetic susceptibility to common cancers. Significance: Systematic evaluation of associations of alternative polyadenylation with cancer risk reveals 58 putative susceptibility genes, highlighting the contribution of genetically regulated alternative polyadenylation of 3′UTRs to genetic susceptibility to cancer.
Year:
2024
Year:
2024
Year:
2022
Collaborators (69)
Li Hsu
Fred Hutchinson Cancer Research Center
Polly Newcomb
University of Washington
Marc Gunter
International Agency for Research on Cancer
Tabitha Harrison
Fred Hutchinson Cancer Research Center
Konstantinos K. Tsilidis
-
Victor Moreno
Professor
University of Barcelona
Marina Evangelou
Senior Lecturer in Statistics
Imperial College London
Fränzel J.B. van Duijnhoven
Wageningen University & Research
Xiao‐Ou Shu
Vanderbilt University Medical Center
Susanna Larsson
Professor at Karolinska Institutet
Karolinska Institutet
Juan Pablo Lewinger
Associate Professor
University of Southern California
John Baron
Professor
University of North Carolina
David Drew
Assistant Professor of Medicine
Massachusetts General Hospital
Qingrun Zhang
Assistant Professor
University of Calgary
Ulrike Peters
Fred Hutchinson Cancer Research Center
Jihyoun Jeon
University of Michigan
Matthew Devall
Assistant Professor
University of Virginia
Sophia Harlid
Umea University
Eric Kawaguchi
Assistant Professor
University of Southern California
Julie R Palmer
Boston University School of Medicine
Wei Zheng
-
Weiqiang Lin
Professor
Zhejiang University
Elizabeth Platz
Professor
Johns Hopkins University
Yingye Zheng
Fred Hutchinson Cancer Research Center
Mariana C. Stern
Professor
University of Southern California
Qiuyin Cai
Professor
Vanderbilt University Medical Center
Tim Bishop
University of Leeds
Ran Tao
Associate Professor
Vanderbilt University Medical Center
Elizabeth Hauser
Duke University
GUOCHONG JIA
Vanderbilt University
Richard Hayes
Professor of Population Health and Environmental Medicine
NYU School of Medicine
Mingyang Song
Associate Professor
Harvard University
Stéphane Bézieau
Université de Nantes
Virginia Díez-Obrero
Vrije Universiteit Amsterdam
Hongmei Nan
Professor
University of Indianapolis
Zhishan Chen
staff Scientist
Vanderbilt University
Emmanouil Bouras
Research associate
Imperial College London
Alicja Wolk
Professor of Nutritional Epidemiology
Karolinska Institutet
Anna H. Wu
Professor
University of Southern California
John Potter
Professor
University of Washington
Xingyi Guo
Associate Professor
Vanderbilt University Medical Center
Bethany Van Guelpen
Umea University
Li Li
University of Virginia
Iris Lansdorp-Vogelaar
Associate Professor
Erasmus University Medical Center
Jirong Long
Professor
Vanderbilt University Medical Center
Andrea Burnett-Hartman
Epidemiologist Program Director
Fred Hutchinson Cancer Research Center
Andrea Gsur
Medical University of Vienna
Loic Le Marchand
Professor
University of Hawaii
Edward A. Ruiz-Narváez
Associate Professor
University of Michigan School of Public Health
Elom K Aglago
Imperial College London
David Conti
Professor
Colorado School of Public Health
W. James Gauderman
professor
University of Southern California
Paul Pharoah
Professor of Cancer Epidemiology
Cedars-Sinai Medical Center
Yaohua Yang
Assistant Professor
University of Virginia
Catherine Tangen
Fred Hutchinson Cancer Research Center
Kala Visvanathan
Professor
Johns Hopkins University
Daniel D. Buchanan
Senior Research Fellow
University of Melbourne
Annika Lindblom
Karolinska Institutet
Stephen Gruber
Professor
City Of Hope National Medical Center
Jochen Hampe
Scientific Speaker
Technische Universität Dresden
Anshul Kundaje
Associate Professor
Stanford University
Mark Jenkins
University of Melbourne
Peter T. Campbell
Professor
Albert Einstein College of Medicine
Graham Giles
Head of Research
-
Michael Hoffmeister
Professor of Epidemiology, Group leader, Deputy divison head
German Cancer Research Center (DKFZ)
Volker Arndt
Group leader
Deutsches Krebsforschungszentrum
Elizabeth Barry
Associate Professor
Dartmouth College Geisel School of Medicine
Pavel Vodička
senior researcher
Charles University
Jennifer Ose
Professorin (W2)
Hochschule Hannover
Make your next move.
Prepare your application
Review drafts before you send them.